A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 74.50
+0.50 (0.68%)
Aug 26, 2026, 1:30 PM CST
A Plus Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 185.79 | 169.38 | 151.06 | -11.31 | 45.7 | 32.94 |
Depreciation & Amortization | 27.04 | 25.13 | 24.56 | 23.39 | 24.86 | 21.43 |
Other Amortization | 2.12 | 2.12 | 2.14 | 2.99 | - | - |
Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 164.46 | - | - |
Loss (Gain) on Equity Investments | -12.32 | -3.66 | - | - | - | - |
Stock-Based Compensation | - | 0.55 | 1.2 | - | - | 1.71 |
Provision & Write-off of Bad Debts | - | - | -0.18 | 0.17 | -0.37 | -0.6 |
Other Operating Activities | 21.41 | 31.5 | 4.17 | -18.4 | 9.47 | 38.25 |
Change in Accounts Receivable | -9.63 | 1.79 | -36.71 | 2.83 | -24.59 | -2.94 |
Change in Inventory | -45.74 | -67.74 | -3.82 | 9.27 | 7.09 | -55.36 |
Change in Accounts Payable | 1.48 | 1.5 | 10.59 | -10.48 | -0.1 | 15.8 |
Change in Unearned Revenue | -1.01 | 2.05 | -0.62 | -5.22 | 5.91 | -1.66 |
Change in Other Net Operating Assets | 0.41 | -3.7 | 8.56 | 1.4 | -7.33 | 3.38 |
Operating Cash Flow | 169.55 | 158.91 | 160.96 | 159.1 | 60.64 | 52.95 |
Operating Cash Flow Growth | -6.09% | -1.27% | 1.17% | 162.36% | 14.53% | -52.81% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -137.39 | -14.12 | -8.87 | -9.38 | -35.12 | -221.5 |
Sale of Property, Plant & Equipment | 0 | 0.27 | - | - | - | - |
Cash Acquisitions | -0.56 | -0.56 | - | - | - | - |
Sale (Purchase) of Intangibles | -1.13 | -0.51 | -0.27 | -0.43 | -1.65 | -3.41 |
Investment in Securities | -86 | -55 | -30 | - | - | - |
Other Investing Activities | 2.78 | -3.59 | 0.09 | 4.96 | 6.27 | -9.32 |
Investing Cash Flow | -222.3 | -73.51 | -39.05 | -4.85 | -30.5 | -234.23 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 5.87 |
Long-Term Debt Issued | - | - | - | - | - | 165 |
Total Debt Issued | 80 | - | - | - | - | 170.87 |
Short-Term Debt Repaid | - | - | - | - | -37.8 | - |
Long-Term Debt Repaid | - | -13.74 | -16.32 | -35.17 | -46.9 | -12.97 |
Total Debt Repaid | -14.28 | -13.74 | -16.32 | -35.17 | -84.7 | -12.97 |
Net Debt Issued (Repaid) | 65.73 | -13.74 | -16.32 | -35.17 | -84.7 | 157.9 |
Issuance of Common Stock | - | 333.02 | 30.32 | - | - | 54.66 |
Repurchase of Common Stock | -43.94 | -38.66 | -16.25 | -14.15 | - | - |
Common Dividends Paid | -170.36 | -121.88 | -81.49 | -21.13 | -15.24 | -14.32 |
Other Financing Activities | 0.95 | -1.9 | 3.26 | 1.27 | 1.12 | -1.08 |
Financing Cash Flow | -147.62 | 156.85 | -80.49 | -69.18 | -98.82 | 197.16 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 10.05 | 1.13 | 0.48 | -3.7 | 1.27 | -0.09 |
Net Cash Flow | -190.32 | 243.38 | 41.9 | 81.38 | -67.41 | 15.78 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 32.15 | 144.79 | 152.09 | 149.72 | 25.52 | -168.55 |
Free Cash Flow Growth | -80.51% | -4.80% | 1.58% | 486.62% | - | - |
Free Cash Flow Margin | 3.62% | 17.32% | 19.76% | 22.18% | 4.15% | -31.11% |
Free Cash Flow Per Share | 0.93 | 4.40 | 5.01 | 4.95 | 0.84 | -5.83 |
Levered Free Cash Flow | -30.84 | 103.99 | 97.17 | 103.93 | 22.28 | -169.04 |
Unlevered Free Cash Flow | -29.28 | 105.34 | 98.54 | 105.61 | 23.94 | -167.67 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 2.49 | 2.17 | 2.19 | 2.69 | 2.64 | 2.18 |
Cash Income Tax Paid | 41.57 | 15.25 | 33.14 | 32.76 | 12.97 | 5.85 |
Change in Working Capital | -54.48 | -66.11 | -22 | -2.2 | -19.02 | -40.79 |